Mast cell receptor linked to alcohol withdrawal-associated headaches

Researchers investigate the role of the mast-cell-specific receptor Mas-related G-protein-coupled receptor B2 (MrgprB2) in alcohol-withdrawal-induced headaches.

Ketogenic diet improves metabolic and mental health in schizophrenia and bipolar disorder patients, study finds

Researchers found that a ketogenic diet significantly improves both metabolic and psychiatric health in individuals with schizophrenia or bipolar disorder, with notable reductions in weight,

May 27, 2024

FLYSYN by VERAXA Biotech for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval

FLYSYN is under clinical development by VERAXA Biotech and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia).

February 9, 2024

Scientists document first-ever transmitted Alzheimer’s cases, tied to no-longer-used medical procedure

LONDON — There was something odd about these Alzheimer’s cases. Part of it was the patients’ presentations: Some didn’t have the classic symptoms of the

January 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.